Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis.
about
Maraviroc: a review of its use in HIV infection and beyondResistance to HIV InfectionLack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis.Chemokine Receptor-5Delta32 Mutation is No Risk Factor for Ischemic-Type Biliary Lesion in Liver Transplantation.CCR5 is involved in resolution of inflammation in proteoglycan-induced arthritis.Association of two functional polymorphisms in the CCR5 gene with juvenile rheumatoid arthritisAssociation of the CCR5 gene with juvenile idiopathic arthritis.Functional CCR5 receptor protects patients with arthritis from high synovial burden of infecting Chlamydia trachomatis.A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulation.Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis.Two-year safety and virologic efficacy of maraviroc in treatment-experienced patients with CCR5-tropic HIV-1 infection: 96-week combined analysis of MOTIVATE 1 and 2.Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial.Possible influence of resistance to malaria in clinical presentation of rheumatoid arthritis: biological significance of natural selection.A comprehensive review of the genetics of juvenile idiopathic arthritis.Negative association of the chemokine receptor CCR5 d32 polymorphism with systemic inflammatory response, extra-articular symptoms and joint erosion in rheumatoid arthritisEfficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findingsDual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases.CCR5 inhibitors in HIV-1 therapy.Inflammatory Cell Migration in Rheumatoid Arthritis: A Comprehensive Review.Successes and failures of chemokine-pathway targeting in rheumatoid arthritis.Considerations About the Role of the CCR5 Gene in Juvenile Idiopathic Arthritis - Look at the Whole or Put All Parts Together?The HIV co-receptor CCR5 regulates osteoclast function.Association between the chemokine receptor 5 delta32 polymorphism and rheumatoid arthritis: a meta-analysis.The Expanding Therapeutic Perspective of CCR5 Blockade.CCR5Δ32 (rs333) polymorphism is associated with the susceptibility to systemic lupus erythematosus in female Brazilian patients.Comparison of the editing patterns and editing efficiencies of TALEN and CRISPR-Cas9 when targeting the human CCR5 gene.The chemokine receptor CCR5 genetic polymorphism and expression in rheumatoid arthritis patients.Differential CCR5Delta32 allelic frequencies in juvenile idiopathic arthritis subtypes: evidence for different regulatory roles of CCR5 in rheumatological diseases.CCR5-Delta32: implications in SLE development.
P2860
Q26778504-C6CC595F-12DC-461B-9234-E69AD53D637CQ27473466-CE29B62D-25A9-4138-AB05-49DB35261481Q33287486-667CF28F-C144-459F-87FC-690B474A0AD8Q33602646-1E1E7FFC-BC97-458E-84CC-050D570365D3Q33677606-C930E465-E12E-4FF4-837C-934D007801D1Q34082362-784E3466-7789-4BAD-8539-319C3A590752Q34282309-9FA79EF7-0330-4F6A-8D35-8AFD826AD014Q34372582-A20B26F8-8901-4B45-AFD7-DC95D3AEA12BQ34389532-FCEB86E6-D3C2-4237-9256-F075F7B7188AQ35014330-C440F538-01E1-4C83-B3B7-6E5E6B110635Q35875096-FAC92728-AC32-437A-B3AD-BC925D6CA62EQ36084912-6C188878-855B-41F0-9979-34D682A86135Q36417884-4EF148AB-A4E6-45BB-96CD-5755458840F1Q36836577-4280EDFF-8048-40B8-8496-65729AD8A21BQ37270859-76DC139C-1D24-4433-BE93-5387EE0F730EQ37613476-A372256C-759C-43FE-B305-4C93C34FF636Q37723178-E2836DDA-B856-46CE-A5E5-54ECB8E614DEQ38089881-2F0C1E83-8C2B-477E-B1E7-3911D4B14546Q38618883-3147B084-F348-42B1-90A4-15D6C28C2A29Q38647749-25CD4D5B-8296-41D5-A4BC-519D80FB97E3Q39979340-21E67984-D505-4F2C-9895-3D09BEB985B8Q47126167-E30A133A-382B-498C-ADF3-3E11A55050CFQ47704813-BD7CFE2D-3926-458F-B57C-1140E2BAFC93Q47800556-AE301CCC-85BE-4C7F-90E2-3797A09683C2Q51016561-268DC5EE-62E5-4DFB-9764-E7115668277FQ52431062-90F9624A-94D0-4268-B080-0DB4A4D4F074Q53519868-2710AF0B-D212-4A2D-8E9A-460B3028CEABQ54551423-791F1D65-A42B-4430-B78D-D0A7F9A089BBQ54688004-69FF0A2A-40B9-4E3E-BE1B-ADC34CC862F4
P2860
Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Evidence for negative associat ...... ism with rheumatoid arthritis.
@ast
Evidence for negative associat ...... ism with rheumatoid arthritis.
@en
type
label
Evidence for negative associat ...... ism with rheumatoid arthritis.
@ast
Evidence for negative associat ...... ism with rheumatoid arthritis.
@en
prefLabel
Evidence for negative associat ...... ism with rheumatoid arthritis.
@ast
Evidence for negative associat ...... ism with rheumatoid arthritis.
@en
P2093
P356
P1476
Evidence for negative associat ...... ism with rheumatoid arthritis.
@en
P2093
Harrison A
Merriman A
Merriman M
P304
P356
10.1136/ARD.2004.023333
P407
P577
2004-08-26T00:00:00Z